Outcome and risk factors of kidney transplantation in the European Senior Program

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021163

Enrollment

200

Registered

2023-06-13

Start date

2019-09-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Z94.0 T86.10

Interventions

Group 1: Kidney transplantation between 2007 and 2017 at the University Hospital of Freiburg within the European Senior Program (ESP). We investigate complications during follow-up, such as infectious

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: kidney transplantation AND date of transplantation 2007-2017 AND ESPor ETKAS (control group)

Exclusion criteria

Exclusion criteria: kidney transplantation at a different time point, combined kidney and pancreas transplantation, living donation

Design outcomes

Primary

Measure	Time frame
Mortality. The primary endpoint is analyzed on the basis of an annual follow-up.	—

Secondary

Measure	Time frame
Acute rejection (biopsy-proven), graft loss, infectious disease, malignancy, hospitalization.	—

Countries

Germany

Contacts

Public ContactJohanna Schneider

Universitätsklinikum Freiburg

johanna.schneider@uniklinik-freiburg.de0761-270 32842

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026